Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.52
-0.24 (-4.17%)
Mar 3, 2026, 4:00 PM EST - Market closed

Foghorn Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-72.12-86.62-98.43-108.88-101.32-68.8
Depreciation & Amortization
3.293.123.453.323.231.33
Stock-Based Compensation
10.6411.8916.1914.348.382.96
Other Adjustments
1.93.472.563.296.024.52
Change in Receivables
---300-300-
Changes in Accounts Payable
-0.24-2.480.851.610.140.47
Changes in Accrued Expenses
-1.65-0.56-1.81.442.653.19
Changes in Unearned Revenue
-24.52-22.6-34.16-14.23336.4814.57
Changes in Other Operating Activities
-5.65-6.63-6.77-7.28-5.8210.47
Operating Cash Flow
-88.35-100.41-118.11193.61-50.25-31.29
Capital Expenditures
-0.53-0.91-1.22-1.21-3.31-16.18
Sale of Property, Plant & Equipment
-----0.25
Purchases of Investments
-136.92-261.47-73.9-409.35-99.98-92.98
Proceeds from Sale of Investments
258.54232.47219.58166.23139.47-
Investing Cash Flow
121.1-29.9144.45-244.3236.17-108.91
Long-Term Debt Issued
-----19.8
Long-Term Debt Repaid
-----21.21-15.53
Net Long-Term Debt Issued (Repaid)
-----21.214.27
Issuance of Common Stock
0.45106.011.781.7643.62123.34
Net Common Stock Issued (Repurchased)
0.45106.011.781.7643.62123.34
Issuance of Preferred Stock
-----89.86
Net Preferred Stock Issued (Repurchased)
-----89.86
Other Financing Activities
-0.2-0.59----
Financing Cash Flow
0.45105.431.781.7622.42217.47
Net Cash Flow
33.2-24.8828.12-48.958.3477.27
Free Cash Flow
-88.88-101.31-119.33192.4-53.56-47.47
FCF Margin
-362.49%-448.24%-349.38%1000.63%-4060.88%-11039.30%
Free Cash Flow Per Share
-1.41-1.85-2.844.63-1.44-4.30
Levered Free Cash Flow
-101.42-116.67-138.08-125.23210.83-50.68
Unlevered Free Cash Flow
-115.81-132.74-142.72-133.48232.62-54.68
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q